<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: Hemodilution using modified <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> solutions may reduce ischemic central <z:mp ids='MP_0008912'>nervous</z:mp> system injury </plain></SENT>
<SENT sid="1" pm="."><plain>Purified diaspirin cross-linked <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> (DCLHb) is a cell-free <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> that is intramolecularly cross-linked between the two alpha subunits, resulting in enhanced oxygen offloading to tissues and increased half-life </plain></SENT>
<SENT sid="2" pm="."><plain>In the present experiments, we evaluated the ability of DCLHb to reduce neurological damage in two rabbit <z:hpo ids='HP_0001297'>stroke</z:hpo> models </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: In a reversible <z:e sem="disease" ids="C0752130" disease_type="Disease or Syndrome" abbrv="">spinal cord ischemia</z:e> model, <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> of the caudal lumbar spinal cord was produced by temporary occlusion of the abdominal aorta </plain></SENT>
<SENT sid="4" pm="."><plain>In an irreversible model of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>, plastic microspheres (50 microns) were injected into the internal carotid artery and lodged in the cerebral microvasculature </plain></SENT>
<SENT sid="5" pm="."><plain>DCLHb was administered 5 minutes after initiation of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> as either a 10-mL/kg infusion, 10-mL/kg exchange transfusion, or a 20-mL/kg infusion </plain></SENT>
<SENT sid="6" pm="."><plain>Control animals received human serum albumin that was oncotically matched to the DCLHb </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: In the spinal cord model, DCLHb significantly increased the duration of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> required to produce permanent <z:hpo ids='HP_0003470'>paralysis</z:hpo> from 27.33 +/- 8.71 minutes (mean +/- SD) in controls to 42.59 +/- 10.10 minutes in the 10-mL/kg exchange transfusion group and to 40.82 +/- 18.16 minutes in the 20-mL/kg infusion condition (P &lt; .05) </plain></SENT>
<SENT sid="8" pm="."><plain>DCLHb did not significantly reduce neurological damage in the microsphere embolization model </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: These data suggest that cross-linked <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> reduces neurological damage after reversible central <z:mp ids='MP_0008912'>nervous</z:mp> system <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and that this is not attributable to hemodilution or <z:hpo ids='HP_0011105'>hypervolemia</z:hpo> only </plain></SENT>
</text></document>